Home

Ausbildung Schneider Gründlich short valeant Therapie notwendig Wässrig

Die Shortsellerin, die schon 2018 gegen Wirecard wettete - Capital.de
Die Shortsellerin, die schon 2018 gegen Wirecard wettete - Capital.de

Valeant shares jump 6 percent after analyst says 'short thesis has been  debunked'
Valeant shares jump 6 percent after analyst says 'short thesis has been debunked'

Fahmi Quadir: Die Shortsellerin, die gegen Valeant und Wirecard wettete |  LGT
Fahmi Quadir: Die Shortsellerin, die gegen Valeant und Wirecard wettete | LGT

Valeant short seller on the money — and facing trial in HK | The Australian
Valeant short seller on the money — and facing trial in HK | The Australian

Valeant Pharmaceuticals Rebuts Short Seller Claims Of Enron-Like Sham  Transactions
Valeant Pharmaceuticals Rebuts Short Seller Claims Of Enron-Like Sham Transactions

Valeant Plunges 30% After Short Seller Citron Research Makes Fraud  Allegation
Valeant Plunges 30% After Short Seller Citron Research Makes Fraud Allegation

What the Average Short Position in Valeant
What the Average Short Position in Valeant

Andrew Left, owner and founder of Citron Research, stands for a...  Nachrichtenfoto - Getty Images
Andrew Left, owner and founder of Citron Research, stands for a... Nachrichtenfoto - Getty Images

Fahmi Quadir: Die Shortsellerin, die gegen Valeant und Wirecard wettete |  LGT
Fahmi Quadir: Die Shortsellerin, die gegen Valeant und Wirecard wettete | LGT

Watch Safkhet Capital's Quadir Is Still Short Valeant - Bloomberg
Watch Safkhet Capital's Quadir Is Still Short Valeant - Bloomberg

Valeant's stock has plunged, so where are all the shorts? - The Globe and  Mail
Valeant's stock has plunged, so where are all the shorts? - The Globe and Mail

Safkhet Capital's Quadir Is Still Short Valeant - YouTube
Safkhet Capital's Quadir Is Still Short Valeant - YouTube

Citron Short Valeant Again
Citron Short Valeant Again

Opinion: Time to short Valeant bonds, go long its stock - MarketWatch
Opinion: Time to short Valeant bonds, go long its stock - MarketWatch

US-Pharmakonzern Valeant: Dieser Skandal könnte Bill Ackman Milliarden und  den Ruf kosten - manager magazin
US-Pharmakonzern Valeant: Dieser Skandal könnte Bill Ackman Milliarden und den Ruf kosten - manager magazin

The 'Short' Who Sank Valeant Stock - WSJ
The 'Short' Who Sank Valeant Stock - WSJ

The Valeant Meltdown and Wall Street's Major Drug Problem | Vanity Fair
The Valeant Meltdown and Wall Street's Major Drug Problem | Vanity Fair

Valeant shares plunge after 'fraud' accusation from short-seller | CBC News
Valeant shares plunge after 'fraud' accusation from short-seller | CBC News

What the Average Short Position in Valeant
What the Average Short Position in Valeant

Famed short-seller Chanos can't cash in on Valeant
Famed short-seller Chanos can't cash in on Valeant

Hacked Printers. Fake Emails. Questionable Friends. Fahmi Quadir Was Up 24%  Last Year, But It Came at a Price. | Institutional Investor
Hacked Printers. Fake Emails. Questionable Friends. Fahmi Quadir Was Up 24% Last Year, But It Came at a Price. | Institutional Investor

The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg

Leerverkäufer : Andrew Left - der Mann, vor dem die Wall Street zittert |  tagesschau.de
Leerverkäufer : Andrew Left - der Mann, vor dem die Wall Street zittert | tagesschau.de

Valeant 'short' smells smoke — even when there's no fire
Valeant 'short' smells smoke — even when there's no fire

Short Seller Famous for Bet Against Valeant Targets Tesla
Short Seller Famous for Bet Against Valeant Targets Tesla